We are live on ! Find out more
ACM

AIGH Capital Management Portfolio holdings

AUM $733M
1-Year Est. Return 327.32%
This Fund
S&P 500
This Quarter Est. Return
+41.06%
1 Year Est. Return
+327.32%
3 Year Est. Return
+1,033.66%
5 Year Est. Return
+1,660.59%
10 Year Est. Return
–
AUM
$355M
AUM Growth
+$133M
Cap. Flow
+$2.48B
Cap. Flow %
699.83%
Top 10 Hldgs %
60.33%
Holding
53
New
18
Increased
5
Reduced
10
Closed
15

Top Buys

Rank Stock Value
1
MXL icon
MaxLinear
MXL
+$17.4M
2
SNDK
Sandisk
SNDK
+$16.4M
3
CSTL icon
Castle Biosciences
CSTL
+$14.4M
4
LUMN icon
Lumen
LUMN
+$12.2M
5
DAWN
Day One Biopharmaceuticals
DAWN
+$10.5M

Top Sells

Rank Stock Value
1
SCPH
scPharmaceuticals
SCPH
+$14.7M
2
LPTH icon
Lightpath Technologies
LPTH
+$12.2M
3
ELVA
Electrovaya
ELVA
+$9.96M
4
BLZE icon
Backblaze
BLZE
+$9.95M
5
VSTM icon
Verastem
VSTM
+$8.31M

Sector Composition

Rank Sector Weight
1 Technology 38.61%
2 Healthcare 31.94%
3 Industrials 5.52%
4 Communication Services 4.4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
STX icon
1
CALL
Seagate
STX
$178B
$37.9M 10.69%
+12,470,132
New +$2.13B
SNDK
2
Sandisk
SNDK
$201B
$31.4M 8.85%
+280,000
New +$16.4M
PSNL icon
3
Personalis
PSNL
$1.61B
$25.4M 7.15%
3,892,101
+168,143
+5% +$957K
DOMO icon
4
Domo
DOMO
$157M
$21.2M 5.99%
1,341,518
– –
ARQ icon
5
Arq
ARQ
$88.4M
$18.5M 5.2%
2,579,486
-75,000
-3% -$495K
MXL icon
6
MaxLinear
MXL
$6.43B
$17.8M 5.02%
+1,107,504
New +$17.4M
LASR icon
7
nLIGHT
LASR
$3.91B
$17.8M 5.01%
600,103
– –
CSTL icon
8
Castle Biosciences
CSTL
$733M
$16.1M 4.54%
+707,287
New +$14.4M
LUMN icon
9
Lumen
LUMN
$6.47B
$15.6M 4.4%
+2,550,000
New +$12.2M
GLW icon
10
CALL
Corning
GLW
$133B
$12.3M 3.48%
3,829,453
+3,654,453
+2,088% +$239M
ZVRA icon
11
Zevra Therapeutics
ZVRA
$755M
$11.7M 3.3%
1,231,932
+313,039
+34% +$3.14M
MBLY icon
12
CALL
Mobileye
MBLY
$7.76B
$11.3M 3.19%
+4,423,008
New +$65.8M
DAWN
13
DELISTED
Day One Biopharmaceuticals
DAWN
$10.7M 3.02%
+1,520,492
New +$10.5M
APPS icon
14
Digital Turbine
APPS
$1.01B
$9.75M 2.75%
+1,523,068
New +$7.56M
BKTI icon
15
BK Technologies
BKTI
$307M
$8.36M 2.36%
+99,009
New +$5.65M
VPG icon
16
Vishay Precision Group
VPG
$1.38B
$8.01M 2.26%
250,000
-173,484
-41% -$5.02M
ESPR
17
DELISTED
Esperion Therapeutics
ESPR
$7.95M 2.24%
+3,000,000
New +$5.8M
ZVRA icon
18
CALL
Zevra Therapeutics
ZVRA
$755M
$7.65M 2.16%
+3,221,110
New +$32.3M
LPTH icon
19
Lightpath Technologies
LPTH
$657M
$7.14M 2.01%
900,000
-2,742,377
-75% -$12.2M
FENC icon
20
Fennec Pharmaceuticals
FENC
$365M
$6.38M 1.8%
681,501
+229,101
+51% +$1.98M
COYA icon
21
Coya Therapeutics
COYA
$106M
$6.3M 1.78%
1,105,622
– –
VELO
22
Velo3D Inc
VELO
$316M
$5.28M 1.49%
+1,719,874
New +$5.95M
PHAT icon
23
Phathom Pharmaceuticals
PHAT
$873M
$5.05M 1.42%
+429,000
New +$4.43M
AMBA icon
24
Ambarella
AMBA
$2.71B
$4.13M 1.16%
+50,000
New +$3.63M
TLPH icon
25
Talphera
TLPH
$68.5M
$3.98M 1.12%
+4,454,545
New +$2.59M
1
2 3

Similar funds

GFI
Global Frontier Investments Charleston, South Carolina $732M AUM 8.6% 1-Year Est. Return
RP
Rice Partnership Honolulu, Hawaii $732M AUM 28.13% 1-Year Est. Return
IA
Intellus Advisors Naples, Florida $732M AUM 29.73% 1-Year Est. Return
SI
Seeds Investor New York $735M AUM 17.54% 1-Year Est. Return
GIC
GFI Investment Counsel Toronto, Ontario, Canada $731M AUM 3.86% 1-Year Est. Return
CT
Colonial Trust Spartanburg, South Carolina $735M AUM 18% 1-Year Est. Return
TWP
TFO Wealth Partners Maumee, Ohio $735M AUM 21.07% 1-Year Est. Return
GWS
Glassman Wealth Services Vienna, Virginia $736M AUM 17.99% 1-Year Est. Return

AIGH Capital Management's Q3 2025 Portfolio in Review

As of Q3 2025, AIGH Capital Management held 53 positions worth $355M, up 60% from $222M the previous quarter. Its ten largest holdings account for 60% of the portfolio.

AIGH Capital Management deployed $2.48B of net new capital in Q3 2025, opening 18 new positions and adding to 5 existing holdings. Its largest new stake was MaxLinear: 1,107,504 shares worth $17.8M.

By sector, the portfolio is most concentrated in Technology at 39% of assets, up from 35% a quarter earlier, followed by Healthcare and Industrials.

On the sell side, the largest reduction was Lightpath Technologies, an estimated $12.2M trimmed.

  • AIGH Capital Management's largest Q3 2025 buy was MaxLinear: 1,107,504 shares worth $17.8M.
  • AIGH Capital Management added most to Zevra Therapeutics in Q3 2025, an estimated $3.14M increase.
  • AIGH Capital Management's biggest Q3 2025 reduction was Lightpath Technologies, cutting an estimated $12.2M.
  • AIGH Capital Management fully exited scPharmaceuticals in Q3 2025, selling an estimated $14.7M.
  • AIGH Capital Management's ten largest holdings make up 60% of its $355M portfolio in Q3 2025.
  • AIGH Capital Management opened 18 new positions and closed 15 in Q3 2025.
  • AIGH Capital Management's portfolio value rose 60% quarter-over-quarter to $355M.

Based on AIGH Capital Management's 13F filing for Q3 2025, filed 31 Oct 2025.